Core COMPASS team

Ekaterina Malievskaia MD MSc

Head of Research & Development and Co-Founder

Dr Ekaterina Malievskaia leads Research and Development at COMPASS.

Ekaterina received her medical degree from St Petersburg Medical Academy in St Petersburg, Russia. After her Internal Medicine residency training, she completed an Environmental Medicine Fellowship at Mount Sinai School of Medicine and received her MSc in Public Health from New York University Medical School. She worked in private practice, academic medicine and public health for more than 15 years in the greater New York area. She was a Clinical Instructor of Medicine at Mount Sinai School of Medicine, as well as a Research Professor at City University of New York.

After moving to London in 2011, Ekaterina worked in global health and medical philanthropy, focusing on improving outcomes in maternal and child health. She founded COMPASS Pathways with her husband George Goldsmith in 2016, having experienced at first-hand the challenges in accessing evidence-based and effective mental health care for a family member.

We have created COMPASS to improve patients’ access to innovation in mental health. Through our personal experiences, we have learned how challenging it could be to find the right treatment and right expertise in time. We also learned that it could make all the difference in the outcomes. We walked that path so others don’t have to.

George Goldsmith

Chairman and Co-Founder

George is a serial entrepreneur with significant experience in pharmaceutical regulation.

George's early training and experience was a multi-disciplinary blending of cognitive psychology, clinical psychology and computer science.His first company, The Human Interface Group, was a pioneer in collaborative software and acquired by Lotus Development. George led the Lotus Institute and developed software and services to support high-performance, distributed teamwork. George then created TomorrowLab, which provided strategic guidance to internet businesses in the late 1990s. At the same time, he became a senior advisor to McKinsey & Company’s leadership, and eventually joined McKinsey as CEO of TomorrowLab@McKinsey. Subsequently, as a member of the Young Presidents Organisation (YPO) and its International Board of Directors, George founded YPO Networks. In 2002, George founded Tapestry Networks, an organisation committed to improving leadership performance and governance effectiveness in regulated sectors. He still serves as Tapestry Networks' Non-Executive Chairman. George also serves on the board of directors for AnaBios, a company redefining drug discovery. He and his wife, Ekaterina Malievskaia MD, live in London.

I have spent my life working with teams of leaders seeking to do extraordinary things. The best of them fight the tendency to accept zero-sum strategies and declare victory. They understand that we can create environments where people suspend disbelief, build trust and chase unlikely combinations of new ideas and technologies.

Lars Christian Wilde

Chief Operating Officer and Co-Founder

Lars is Co-Founder and Chief Operating Officer of COMPASS Pathways, focusing on operations, digital health solutions and fundraising.

Lars is also active as a business angel investor and advisor, and has helped to successfully build companies such as Otto Wilde Grillers and Emma & Noah. Before joining COMPASS, Lars was the founder and CEO of Springlane, the leading German kitchen equipment online retailer and the largest German cooking magazine. Being a hobby chef himself, Lars realised that cooking was moving from being a daily chore to becoming an interest for an increasingly large number of people. Exploiting this, Lars built Springlane from a two person business into a company that produces its own brands and product ranges, is active in several European countries, runs offline retail stores, and has raised more than 30m EUR in capital from some of the leading European venture capital firms. Lars previously worked as an investor at Waterland Private Equity, the world’s best performing private equity fund. Amongst other buy-and-build investments, he focused on building VivaNeo, the largest European in-vitro fertilization group, providing patients with cutting edge medical solutions. Lars has also spent time with Boston Consulting Group in Munich and Sao Paulo. Lars holds a Masters in Finance with distinction from IE Business School in Spain and a Bachelor of Science in Business Administration with distinction from Rotterdam School of Management, Erasmus University in the Netherlands. Lars spent exchange semesters at Westfälische Wilhelms-Universität Münster, Copenhagen Business School and the Ross School of Business at the University of Michigan.

I have witnessed how devastating the impact of depression can be on a person’s life in my close circle of friends. My friend had the privilege of being treated with psilocybin and he has been relieved of the debilitating disease ever since. Unfortunately, this treatment is not available to most people in the world and its efficacy has yet to be proven in large scale clinical trials. Having founded and invested in several companies in the past, I recognised that COMPASS offers the opportunity to build something immensely beneficial for our global society. I am excited by the outlook of solving one of humanity’s largest unmet medical needs together with an extremely smart and vision driven team.

Hans Eriksson

Chief Medical Officer

Hans is Chief Medical Officer of COMPASS Pathways, leading the clinical development programme.

Hans gained his MD and did his residency in psychiatry at Lund University in Sweden. He also holds a PhD in Cell and Molecular Biology from Lund University, and an executive MBA from Stockholm School of Economics. After having worked as consultant psychiatrist and assisting head of the Psychiatric Centre at Lund University Hospital, he moved to the pharmaceutical industry in 2000. He has been working in different roles with H. Lundbeck and AstraZeneca, especially on the development programmes for escitalopram, quetiapine XR, mecamylamine, and brexpiprazole for major depressive disorder, and for additional psychiatric indications. He had an active role in the successful regulatory submissions of Cipralex, Seroquel XR and Rexulti. He was the global medical lead for Seroquel XR at AstraZeneca, and in his most recent role he was Senior Director and head of clinical development for depression and paediatrics at H. Lundbeck. At COMPASS Pathways, Hans uses his clinical expertise and clinical development experience to lead the development programme.

It is a truly meaningful effort to participate in the development of a novel treatment paradigm for people suffering from severe mental disorders.

Marco Mohwinckel

Chief Commercial Officer

Marco is Chief Commercial Officer at COMPASS Pathways, leading on commercial strategy.

Throughout his career, Marco has been an outspoken advocate for change, innovation and entrepreneurship in healthcare. Over the past 15 years he led strategy and commercial operations for digital and pharmaceutical companies across various therapeutic areas and continents. Most recently he was VP of Strategy at WebMD / Medscape, the leading online health information platform for consumers and healthcare professionals; previously he worked at Johnson & Johnson as Global Head of Janssen Healthcare Innovation, where he was part of the Global Commercial Strategy Leadership Team, and as head of the Neuroscience Business Unit in the UK. As management consultant at the Monitor Group, he advised life-science and technology companies on growth strategies, market access, product launches, operational excellence, business development and strategic partnerships. Marco is an active advisor and independent board member in several health-tech start-ups and digital health networks. He engages in public speaking on digital health innovation and has co-authored several articles, most notably “Beyond magic bullets: True Innovation in Healthcare” (Nature Reviews Drug Discovery, 2013), arguing for the need to develop holistic solutions and new business models for patients suffering with mental illnesses.

In the next few years, we will see significant breakthroughs in the treatment of many 'silent' and debilitating mental health conditions, like depression, which affect millions of people around us. Having worked in this field for years, I am excited to be part of COMPASS on a pioneering mission to build and cross bridges that lead to a better future; one without prejudice or stigma, where empowered individuals have universal access to the best possible treatment and support.

Joe Heinen

Chief Financial Officer

Joe is a senior finance professional with over 15 years of experience working with entrepreneurs to establish and lead early-stage companies in the US and Europe.

Joe has been working with COMPASS from the beginning. He is responsible for the financial operations of the firm. Joe is also the CFO of Tapestry Networks, a Boston-based professional services firm focused on helping leaders of some of the world’s most important institutions do their work more effectively and with greater confidence. Prior to Tapestry and COMPASS, Joe worked as an independent consultant offering CFO services to early stage companies and, before that, he worked in fixed income sales and trading with Goldman Sachs in New York. Joe earned a undergraduate degree in engineering from the University of Wisconsin and a master’s degree in finance from the Kellogg School of Management.

I‘ve known George & Katya for years and their passion for building an organisation that could one day provide access to this innovative therapy for millions of patients suffering from debilitating mental illness was contagious. I knew early on that I wanted to be on this journey with them.

John Boghossian

Director of Operations

John is Director of Operations at COMPASS. He focuses on daily operations, Market Access and commercial strategy, partnerships, and fundraising.

Before joining COMPASS, John attended the Harvard Business School (HBS) for an MBA. During and after his studies he co-founded a technology company focused on enterprise productivity software. Before HBS, he worked at the Boston Consulting Group (BCG) and specialised in healthcare. He advised global pharmaceutical companies as well as hospital networks across Western Europe and North America. His experience includes R&D strategy, new drug market access strategy, and value-based healthcare outcome measurement. Before BCG, John graduated from the Massachusetts Institute of Technology (MIT) with bachelors in mechanical engineering and economics with distinction, and from the University of Cambridge with a masters in Energy Technologies with distinction. An avid traveller, he calls both sides of the Atlantic home.

My goal is to work on a mission-driven early-stage venture with like-minded people. The mission of COMPASS aligns perfectly with my belief in innovative outcome-based healthcare delivery models, in a therapeutic area with significant unmet medical need. I'm excited to be, together with the whole COMPASS team, on the journey to provide new alternatives to mental health disorders like treatment-resistant depression worldwide.

Tracy Cheung

Director of Communications

Tracy Cheung has more than 25 years’ experience in strategic communications, working with senior executive teams on public affairs, investor and media relations, corporate communications, marketing communications and employee engagement.

Tracy began her career in communications consultancy, working at Rowland Sallingbury Casey and Brunswick. She has since led communications teams in a number of healthcare and life sciences organisations, including Amersham International, GE Healthcare Medical Diagnostics and Essentia (part of Guy’s and St Thomas’ NHS Foundation Trust). Tracy is also a coach with Parent Gym, an evidence-based philanthropic programme designed to support parents in raising happy and confident children.  

What I love about COMPASS is the absolute commitment to putting patients at the centre of everything we do, and the determination to help those suffering with mental illness.

Sue Stansfield

Director of Clinical Trial Programme

Sue is Director of Clinical Trials at COMPASS, leading the global clinical trials programme.

Sue gained her PhD in neuroendocrinology in the 1980s and began her career at Wellcome Research Labs, working on the successful registration of Lamictal®. She moved onto Janssen and Parke-Davies in increasingly senior roles in CNS drug development (anxiety, depression, epilepsy, Alzheimer’s Disease). In 1991, Sue joined Quintiles as the Global Project Director leading the development of a reversible inhibitor of monoamine oxidase A (RIMA) towards an NDA (US new drug application) in panic disorder and social phobia with line extension outside USA. From there, Sue pursued a career in the Clinical Research Organisation (CRO) industry that spanned 25 years. She has worked for a number of leading CROs including Quintiles (now IQVIA) PPD, PRA, Premier Research and inVentiv Health (now Syneos Health), successively expanding her remit with additional functions and regions. At COMPASS Pathways, Sue combines her scientific experience with her trial execution expertise to develop and lead the clinical trials programme.

It is so refreshing to work in such a dynamic team with one single agenda; to overcome the barriers in order to benefit patients.

Sarah Drummond

Executive Personal Assistant

Sarah is an Executive Personal Assistant with over 20 years’ experience.

Before joining COMPASS she worked as George Goldsmith’s Executive PA at Tapestry Networks, a company dedicated to bringing together leaders from business and institutions to help make the world better by making it run better,  for 10 years.  During her time as an EA she has worked in a number of different sectors in London including surveyors, media, finance, consulting and professional services.

I believe COMPASS can make a real and positive difference to the unmet medical needs surrounding mental health and well-being.

Molly Lennard-Jones

Therapist Training Coordinator

Molly focuses on therapist training, therapist recruitment, and is working on qualitative research projects.

Before joining COMPASS, Molly studied English Literature at masters level looking at PTSD in Holocaust Literature. This sparked an interest in mental health research and lead to her to pursue a career in clinical trials; so that she could help translate academic research into real-life treatments. It is this that lead her to COMPASS.

“Working at COMPASS, every day brings new challenges; and with that comes the opportunity to learn from a highly motivated and talented team whose primary philosophies are grounded in patient empowerment. Being a part of something that will make positive impacts on the lives of patients is truly incredible.”

Manon Veraart

Director of Business Development

Professional with over 5 years of experience in investment banking and management consulting and a background in psychology. At COMPASS, Manon focuses on operations, investor relations and partnerships.

Prior to joining COMPASS, Manon worked at the Boston Consulting Group (BCG) in London. She joined BCG after graduating from the INSEAD MBA programme (with distinction). During her MBA, she completed an internship at Aleph Capital Partners (investment firm). Before INSEAD, Manon worked first as an Analyst and later as an Associate in the Natural Resources M&A team of Goldman Sachs in London. Manon is originally from the Netherlands and holds a Master (with distinction) and Bachelor in Business Administration from Erasmus University (Rotterdam) and a Bachelor in Psychology from Leiden University. Manon spent exchange semesters at the University of Southern California, Los Angeles and INCAE, Costa Rica.

I love being part of a highly diverse and collaborative team that is working hard to relieve and solve mental health problems; an issue so many people struggle with. Being able to work on this together, with the ultimate goal of empowering patients globally, motivates me every day.

Samuel I Williams

Associate Project Manager, Clinical Trials Programme

Sam is the Associate Project Manager of the Clinical Trials Programme at COMPASS. He focuses on planning, managing and executing the procedures required for clinical trial progression. 

Sam started working in clinical research during his Master’s degree and has been in this line of work ever since. After graduating, Sam worked at PAREXEL and Covance in different project management support roles in clinical technology solutions and clinical operations. Following this, Sam worked in the NHS, in research service delivery. His most recent post before joining COMPASS, was as the Research Manager for the Acute Medicine Directorate at Guy’s and St Thomas’ NHS Foundation trust. Here, Sam oversaw and advised different teams, the set up and management of commercial and non-commercial trials and research governance across the different clinical services in the directorate.

The innovative approach to therapy, the team of experts and the real drive to empower patients makes being part of the COMPASS team truly an amazing experience.

Monique Superville

Associate Project Manager, Clinical Trials Programme (North America)

Monique is responsible for managing clinical trials operations across the US and Canadian sites.

Prior to joining COMPASS, Monique was the QA/I Manager at NYU School of Medicine where she managed a team of clinical research auditors. Before NYU, she performed clinical research audits as a Senior Human Subjects Protection Analyst at Rutgers University. Prior to Rutgers, she was the Compliance Oversight Manager at Columbia University IRB where she led a clinical research audit team. At all three institutions, the audit activities crossed all medical disciplines. In addition to audits, she assisted researchers with external inspection preparation, study team development and education, and the writing and implementation of Correction and Preventative Action (CAPA) plans. Monique holds a Master of Arts in Applied Psychology from Columbia University and a Bachelor of Arts from The New School for Social Research. She is also a Certified Clinical Research Professional (CCRP).

It’s exciting to be part of a team of talented people with such a broad variety of experience, coming together to accomplish something truly groundbreaking.

Rachel Winzer

Therapist Training Programme Coordinator (North America)

Rachel is responsible for the roll-out and implementation of COMPASS' therapist training across US and Canadian sites. 

Before joining COMPASS, Rachel worked as a mental health specialist at the McLean Franciscan inpatient psychiatric unit in Boston, helping patients and their families manage a wide variety of challenges. Before McLean, Rachel was a behavioral treatment counselor at Germaine Lawrence in Boston, a residential treatment center for adolescents, specializing in trauma and PTSD. Rachel holds a Master of Science in Social Cognition (with distinction) from University College London and a Bachelor of Psychology from University of Colorado Boulder.

“Being a part of the COMPASS team and collaborating with like-minded individuals to further human-centered research and improve lives ignites a sense of purpose and passion in me. We are motivated daily by our collective desire to break down barriers to high quality treatment and combat mental health issues with innovative therapies.”

Anais Soula

Research Analyst

Anais focuses on the design of the Phase 3 clinical trial and market access strategy.

After graduating, with distinction, from a Master’s in Cellular Biology, Physiology and Pathology at the University of Bordeaux, Anais obtained fellowships from the French Ministry of Education and the Fondation pour la Recherche Medicale to carry out her PhD in Molecular Biology and Neuroscience at the Interdisciplinary Institute for Neuroscience. During her PhD, Anais explored new ways of communication between brain cells based on the exchange of extracellular vesicles. Keen on integrating cutting-edge science into society, she pursued a Master’s in Technology and Innovation Management alongside her PhD at the University of Paris-Sud.

At COMPASS, I hope to leverage my scientific background to contribute to the creation of novel treatments for mental health problems.

Jessica Rose Stuart

Team Coordinator

Jess focuses on enabling the COMPASS team to implement the clinical trials programme effectively by providing efficient administrative support.

Jess graduated from Warwick University with a degree in English and American Literature and developed a passion for psychology through voluntary work undertaken during her studies. Jess worked in the media for a number of years before joining a psychology practice, The House Partnership. As Practice Manager, she gained extensive administrative experience in the mental healthcare field by fulfilling a wide range of responsibilities, which included acting as the first point of contact for clients seeking talking therapy and providing diary management for a team of 15 psychologists.

It is incredibly motivating to be part of an accomplished and dedicated team who share the belief that it is possible to end the suffering caused by mental health disorders. Supporting COMPASS to implement an innovative and patient-centred approach to treatment is refreshing and truly inspiring